Alternatives to Anamnesis Bio

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Global biotechnology company pioneering innovative medicines for complex neurological, neuropsychiatric, and rare diseases.

Leveraging the adaptive immune system to diagnose and treat disease.

A global oncology company developing and commercializing innovative cancer treatments.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

AI-powered platform for personalized cell therapy development and manufacturing.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Gene therapy company developing treatments for rare inherited diseases.

Gene therapy company developing transformative treatments for severe genetic diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Biotech company focused on developing therapies to extend human healthspan and lifespan.

Global marketplace connecting researchers with human biospecimens for life science research.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

AI-powered platform for antibody discovery and development to create new medicines.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

A clinical-stage AI drug discovery company accelerating the development of novel therapeutics for various diseases.

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

Develops advanced gene editing and cell therapy solutions for rare genetic diseases.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

BioAge Labs is a biotechnology company focused on developing therapies to extend human healthspan and lifespan.

Biotechnology company developing novel therapeutics to promote healthy longevity by understanding aging pathways.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Developing engineered biologics to harness the immune system for disease treatment.

Teknova provides critical reagents for biopharmaceutical product development and production.

Cloud-native platform for scalable and reproducible bioinformatics workflows.

Mapping cell-cell communication at scale in human tissue.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Clinical-stage biopharmaceutical company developing gene therapies for rare genetic diseases.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.

Irish BioTech startup Aerska raises €32 million to enable loved ones to live longer.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Biotechnology company developing novel immunotherapies for cancer.

Advance every cancer decision.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.